CHANGES IN PHOSPHORUS METABOLISM IN CHRONIC HEART FAILURE WITH RENAL DYSFUNCTION AND EFFECTS OF VITAMIN D SUPPLEMENTATION

Authors

  • Shovkat Sh. Quchkorov Researcher Fergana Institute Of Public Health, Uzbekistan
  • Abdigaffar G. Gadaev Researcher Tashkent Medical Academy, Uzbekistan
  • Onajon U. Abutalipova Researcher Tashkent Medical Academy, Uzbekistan

Keywords:

Chronic kidney disease (CKD), left ventricular ejection fraction (LVEF), hyperphosphatemia

Abstract

The article presents changes in phosphorus indicators in patients with chronic heart failure and advanced kidney dysfunction. Also, on the basis of standard treatment, the combined use of sodium glucose type 2 inhibitor empagliflozin and vitamin D has been found to have a positive effect on electrolyte balance and kidney dysfunction.

Downloads

Download data is not yet available.

References

Dundar ZD, Cander B, Gul M, Karabulut KU, Kocak S, Girisgin S et al. Serum intestinal fatty acid binding protein and phosphate levels in the diagnosis of acute intestinal ischemia: an experimental study in rabbits. J Emerg Med. 2012;42 (6):741–7. DOI:10.1016/j.jemermed.2011.05.051.

Howard SC, Jones DP, Pui C-H. The tumor lysis syndrome. N Engl J Med. 2011;364 (19):1844–54. DOI:10.1056/NEJMra0904569.

Maiya S, Sullivan I, Allgrove J, Yates R, Malone M, Brain C et al. : an important, but preventable, 58 ISSN 0022-9040. Кардиология. 2018;58(S2) cause of life-threatening infant heart failure. Heart. 2008;94 (5):581–4. DOI:10.1136/hrt.2007.119792.

Rozentryt P, Niedziela JT, Hudzik B, Doehner W, Jankowska EA, Nowak J et al. Abnormal serum calcium levels are associated with clinical response to maximization of heart failure therapy. Pol Arch Med Wewn. 2015;125 (1–2):54–64.

Rozentryt P, Nowak J, Niedziela J, Hudzik B, Doehner W, Jankowska EA et al. Serum phosphorus level is related to degree of clinical response to up-titration of heart failure pharmacotherapy. Int J Cardiol. 2014;177 (1):248–54. DOI:10.1016/ j.ijcard.2014.09.034.

Shroff R. Phosphate is a vascular toxin. Pediatr Nephrol. 2013;28 (4):583–93. DOI:10.1007/s00467-012-2347-x.

McCullough P.A., Kellum J.A., Haase M., et al. Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). // Contrib Nephrol. 2013; 182:82–98.

Ponikowski P. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart fai lure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail.2016; 18(8): 891-975.

World Health Organization. Preventing chronic diseases: a vital investment. WHO global report. - Geneva, Switz: World Health Organization, 2005.

Белоусов Ю. Б. Диастолическая дисфункция левого желудочка при хронической сердечной недостаточности: вопросы патогенеза, диагностики, лечения / Ю. Б. Белоусов, Н. Ю. Ханина, А. А. Упницкий // Клин. медицина. -2001. - № 2. - С. 17-21.

Веснина Ж. В., Арсеньева Ю. А. Кардиоренальный синдром: современные взгляды на проблему взаимосвязи заболеваний почек и сердечно-сосудистой системы. // Клиническая медицина, № 7. – 2012. – С. 8- 13.

Веснина Ж. В., Пекарская М. В., Павлюкова Е. Н., Лишманов Ю. Б. Радионуклидные методы в оценке взаимосвязи нарушений центральной гемодинамики и функциональной активности почек у больных с недостаточностью кровообращения. // Сердеч. недостат. 2007; 8 (4): 170— 174.

Гуревич М.А., Кузьменко Н.А. Блокада альдостерона в лечении артериальной гипертензии (аспекты применения эплеренона). Кардиология. РМЖ «Медицинское обозрение» №11 от 31.05.2017 стр. 776-779.

Кобалава Ж.Д., Медовщиков В.В., Ешниязов Н.Б. На пути к квадротерапии сердечной недостаточности с низкой фракцией выброса: данные вторичных анализов DAPA-HF. // Российский кардиологический журнал. 2020; 25(5): 3870. с. 71-80.

Downloads

Published

2024-04-30

How to Cite

Shovkat Sh. Quchkorov, Abdigaffar G. Gadaev, & Onajon U. Abutalipova. (2024). CHANGES IN PHOSPHORUS METABOLISM IN CHRONIC HEART FAILURE WITH RENAL DYSFUNCTION AND EFFECTS OF VITAMIN D SUPPLEMENTATION. International Scientific and Current Research Conferences, 1(01), 102–106. Retrieved from https://orientalpublication.com/index.php/iscrc/article/view/1524

Issue

2024: MIND, MATTER, AND MEANING: UNITING NEUROSCIENCE, PHILOSOPHY, AND COGNITIVE SCIENCE

Section

Articles

License

Copyright (c) 2024 Shovkat Sh. Quchkorov, Abdigaffar G. Gadaev, Onajon U. Abutalipova

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The content published on the International Scientific and Current Research Conferences platform, including conference papers, abstracts, and presentations, is made available under an open-access model. Users are free to access, share, and distribute this content, provided that proper attribution is given to the original authors and the source.